Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene

Human Mutation

Volumn 12, Issue 6, 1998, Pages 417-423

  Stolle, Catherine ^a   Glenn, Gladys ^b   Zbar, Berton ^c   Humphrey, Jeffrey S ^d   Choyke, Peter ^e   Walther, McClellan ^b   Pack, Svetlanna ^b   Hurley, Kathy ^b   Andrey, Carolyn ^b   Klausner, Richard ^b   Marston Linehan, W ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTRUMENTS   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Germline mutation; Pheochromocytoma; Renal cell carcinoma; Southern blotting; Von Hippel Lindau disease

Indexed keywords

ARTICLE; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MUTATION; GENE REARRANGEMENT; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

BLOTTING, SOUTHERN; DNA MUTATIONAL ANALYSIS; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HIPPEL-LINDAU DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIGASES; PROTEINS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 7844234770     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K     Document Type: Article

References (23)

1. Beroud C, Joly D, Gallou C, Staroz F, Ofanelli MT, Junien C (1998): Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 26:256-258.
2. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra RJ, Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Li H, Wei MW, Schmidt L, Tory K, Kuzmin I, Stackhouse T Latif F, Linehan WM, Lerman M, Zbar B (1995): Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype. Hum Mutat 5:66-75.
3. Clinical Research Group for Japan (1995): Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Hum Mol Genet 4:2233-2237.
4. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara AA, Ferguson-Smith A, Maher ER (1994): Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum Mol Genet 3:1303-1308.
5. Glavac D, Neumann HP, Wittke C, Jaenig H, Masek O, Streicher T, Pausch F, Engelhardt D, Plate KH, Hofler H, Chen F, Zbar B, Brauch H (1996): Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum Genet 98:271-280.
6. Glenn GM, Choyke PL, Zbar B, Linehan W (1990): von Hippel-Lindau disease: clinical review and molecular genetics. Problems in Urology 4:312-330.
7. Gnarra JR, Zhou S, Merrill MJ, Wagner J, Krumm A, Papavassiliou E, Oldfield EH, Klausner RD, Linehan WM (1996). Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the von Hippel-Lindau tumor suppressor gene. Proc Natl Acad Sci USA 93:10589-10594.
8. Iliopoulos O, Jiang C, Levy AP, Kaelin WG, Goldberg MA (1996): Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Nat Acad Sci USA 93:10595-10599.
9. Ivanov S, Kuzmin I, Wei M-H, Pack S, Geil L, Johnson BE, Stanbridgre E, Lerman MI (1998): Down regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild type VHL transgenes. Proc Nat Acad Sci in press.
10. Knebelmann B, Ananth S, Cohen HT, Sukhatme VP (1998): Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor. Cancer Res 58:226-231.
11. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MW, Chen F, Glenn G, Choyke P, Wlather MM, Weng Y, Duan D-SR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI (1993): Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320.
12. Maher ER, Kaelin WG, Jr (1997): von Hippel-Lindau disease. Medicine (Baltimore) 76:381-391.
13. Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ, Moore AT (1996): Phenotypic expression in von Hippel-Lindau disease: correlation with germline VHL gene mutations. J Med Genet 33:328-332.
14. Pause A, Lee S, Lonergan JM, Klausner RD (1998): The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc Natl Acad Sci USA 95:993-998.
15. Richards FM, Latif F, Lerman MI, Zbar B, Maher ER (1993): Taq I and Pst I RFLPs in the von Hippel-Lindau disease gene (VHL). Hum Mol Genet 2:1750.
16. Richards FM, Phipps ME, Latif F, Yao M, Crossey PA, Foster K, Linehan WM, Affara NA, Lerman MI, Zbar B, Ferguson-Smith MA, Maher ER (1993): Mapping the von Hippel Lindau tumour suppressor gene. Identification of germline deletions by pulsed field gel electrophoresis. Hum Mol Genet 2:879-882.
17. Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marme D (1996). Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by the von Hippel Lindau protein. Cancer Res 56.2299-2301.
18. Southern EM (1975): Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503-517.
19. o-39 thalassemic transcripts in cell-free extracts. Blood 70:293-300.
20. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins JS, Neumann HPH, Laidlaw J, Li FP, Klein-Szanto AJP, Seizinger BR, Kley N (1994): Germ-line mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55:1092-1102.
21. Yao M, Latif F, Orcutt ML, Kuzmin I, Stackhouse T, Zhou FW, Tory K, Duh FM, Richards F, Maher E, LaForgia S, Huebner, K, Le Paslier D, Linehan WM, Lerman M, Zbar B (1993): von Hippel-Lindau disease: identification of deletion mutations by pulsed field gel electrophoresis. Hum Genet 92:605-614.
22. Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson-Smith MA, Brauch H, Dlavac D, Neumann HP, Tisherman S, Mulvihill JJ, Gross DJ, Shuin T, Whaley J, Seizinger B, Kley N, Olschwang S, Boisson C, Richard D, Lips CH, Lerman M (1996). Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe and Japan. Hum Mutat 8:348-357.
23. Zbar B (1995): von Hippel-Lindau disease and sporadic renal carcinoma. Cancer Surveys 25:219-232.